G599(P) Design and implementation of a database for real-time reporting and analytics of paediatric allergy outpatient clinic attendances and outcomes in the north west of England and North Wales. (25th October 2020) - Denaxa, D
Abstract : Aim: Outpatient workload for paediatric specialities across a region, let alone within a specific centre is usually difficult to gauge. We aimed to develop an online database for recording and assessing workload in real-time. Method: The University of Manchester in conjunction with the North West Paediatric Allergy Network developed and implemented a secure database utilising an online-system of live recording and collation of the workload and outcomes of children with allergies presenting to 21 paediatric secondary and tertiary centres across the whole North West of England and North Wales seeing children with allergies. Results: In a 9-month period from January to September 2019, 3, 600 patient events were recorded across the two regions. 34% were new patients, 53% follow-up patients, 5% telephone consultations and 8% did not attend their appointments. Eighty one percent of children had suffered immediate hypersensitivity reactions, of which 85% were children with food allergies. The 'big four' food allergies accounting for 81% of all children with food allergies were milk, egg, peanut and tree nuts. Only 19% of patients were discharged after their clinic appointment, while the remainder were followed up, 19% of whom were put forward for a formal food challenge to confirm their allergies. Fourteen percent of children were either on oral immunosuppressants or biologics (1%) or immunotherapy (oral immunotherapy for food allergies (9%), subcutaneous or sublingual immunotherapy for aeroallergies (4%)). Conclusion: Our online system for recording and collating of clinical workload and outcomes allows for immediate review of the number and types of allergies children suffered across the regions. Comparisons in terms of efficiency and outlies were easily detected. The data allowed us to develop business cases to meet current demands, as well as management pathways to streamline allergy management.